Small Molecule-Activated O-GlcNAcase for Spatiotemporal Removal of O-GlcNAc in Live Cells.

The nutrient sensor O-linked N-acetylglucosamine (O-GlcNAc) is a post-translational modification found on thousands of nucleocytoplasmic proteins. O-GlcNAc levels in cells dynamically respond to environmental cues in a temporal and spatial manner, leading to altered signal transduction and functional effects. The spatiotemporal regulation of O-GlcNAc levels would accelerate functional interrogation of O-GlcNAc and manipulation of cell behaviors for desired outcomes. Here, we report a strategy for spatiotemporal reduction of O-GlcNAc in live cells by designing an O-GlcNAcase (OGA) fused to an intein triggered by 4-hydroxytamoxifen (4-HT). After rational protein engineering and optimization, we identified an OGA-intein variant whose deglycosidase activity can be triggered in the desired subcellular compartments by 4-HT in a time- and dose-dependent manner. Finally, we demonstrated that 4-HT activation of the OGA-intein fusion can likewise potentiate inhibitory effects in breast cancer cells by virtue of the reduction of O-GlcNAc. The spatiotemporal control of O-GlcNAc through the chemically activatable OGA-intein fusion will facilitate the manipulation and functional understanding of O-GlcNAc in live cells.

[1]  Ronghu Wu,et al.  Spatial and temporal proteomics reveals the distinct distributions and dynamics of O-GlcNAcylated proteins , 2022, Cell reports.

[2]  Xiyun Yan,et al.  Dynamic O-GlcNAcylation coordinates ferritinophagy and mitophagy to activate ferroptosis , 2022, Cell discovery.

[3]  Alexandria K. D’Souza,et al.  Writing and Erasing O-GlcNAc on Casein Kinase 2 Alpha Alters the Phosphoproteome. , 2022, ACS chemical biology.

[4]  Yinping Tian,et al.  Spatiotemporal Activation of Protein O-GlcNAcylation in Living Cells. , 2022, Journal of the American Chemical Society.

[5]  James E. Dahlman,et al.  Drug delivery systems for RNA therapeutics , 2022, Nature Reviews Genetics.

[6]  Christina M. Woo,et al.  O‐GlcNAc Engineering on a Target Protein in Cells with Nanobody‐OGT and Nanobody‐splitOGA , 2021, Current protocols.

[7]  Peng R. Chen,et al.  Unleashing the Power of Bond Cleavage Chemistry in Living Systems , 2021, ACS central science.

[8]  F. He,et al.  Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation. , 2021, Molecular cell.

[9]  Alexandria K. D’Souza,et al.  Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase , 2021, Nature Chemical Biology.

[10]  N. Gray,et al.  Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferase , 2020, Proceedings of the National Academy of Sciences.

[11]  Damien Y. Duveau,et al.  O-GlcNAc regulates gene expression by controlling detained intron splicing , 2020, bioRxiv.

[12]  Hung-Yi Wu,et al.  Engineering a Proximity-Directed O-GlcNAc Transferase for Selective Protein O-GlcNAcylation in Cells. , 2020, ACS chemical biology.

[13]  T. Muir,et al.  Chemoenzymatic Semisynthesis of Proteins. , 2019, Chemical reviews.

[14]  D. V. van Aalten,et al.  Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation , 2019, Nature Structural & Molecular Biology.

[15]  Damien Y. Duveau,et al.  Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors. , 2018, Journal of the American Chemical Society.

[16]  A. Giordano,et al.  Mechanisms of resistance in estrogen receptor positive breast cancer: overcoming resistance to tamoxifen/aromatase inhibitors , 2018, Current opinion in pharmacology.

[17]  Kathryn A. O’Donnell,et al.  A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis , 2017, Cell reports.

[18]  Sujata Sharma,et al.  Insights into activity and inhibition from the crystal structure of human O-GlcNAcase. , 2017, Nature chemical biology.

[19]  Xiaoyong Yang,et al.  Protein O-GlcNAcylation: emerging mechanisms and functions , 2017, Nature Reviews Molecular Cell Biology.

[20]  G. Davies,et al.  Structural and functional insight into human O-GlcNAcase , 2017, Nature chemical biology.

[21]  Jiaoyang Jiang,et al.  Structures of human O-GlcNAcase and its complexes reveal a new substrate recognition mode , 2017, Nature Structural &Molecular Biology.

[22]  C. Bertozzi,et al.  Isotope Targeted Glycoproteomics (IsoTaG) to Characterize Intact, Metabolically Labeled Glycopeptides from Complex Proteomes , 2016, Current protocols in chemical biology.

[23]  David R. Liu,et al.  Small Molecule-Triggered Cas9 Protein with Improved Genome-Editing Specificity , 2015, Nature chemical biology.

[24]  C. Slawson,et al.  O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis , 2014, Front. Endocrinol..

[25]  M. Reginato,et al.  O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. , 2014, Molecular cell.

[26]  Natalya I. Topilina,et al.  Recent advances in in vivo applications of intein-mediated protein splicing , 2014, Mobile DNA.

[27]  Junfeng Ma,et al.  Protein O-GlcNAcylation in diabetes and diabetic complications , 2013, Expert review of proteomics.

[28]  Thierry N'Tumba-Byn,et al.  O-GlcNAcylation-Inducing Treatments Inhibit Estrogen Receptor α Expression and Confer Resistance to 4-OH-Tamoxifen in Human Breast Cancer-Derived MCF-7 Cells , 2013, PloS one.

[29]  Feng Ding,et al.  Rational design of a ligand-controlled protein conformational switch , 2013, Proceedings of the National Academy of Sciences.

[30]  Gerald W. Hart,et al.  O-GlcNAc signalling: implications for cancer cell biology , 2011, Nature Reviews Cancer.

[31]  David R. Liu,et al.  Directed evolution of a small-molecule-triggered intein with improved splicing properties in mammalian cells. , 2011, Chemistry & biology.

[32]  M. Bryś,et al.  Gene expression of O-GlcNAc cycling enzymes in human breast cancers , 2011, Clinical and Experimental Medicine.

[33]  A. Caro-Maldonado,et al.  Sugar-free approaches to cancer cell killing , 2011, Oncogene.

[34]  G. Sethi,et al.  Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1 , 2010, Oncogene.

[35]  J. Zorn,et al.  Turning enzymes ON with small molecules. , 2010, Nature chemical biology.

[36]  G. Davies,et al.  A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. , 2008, Nature chemical biology.

[37]  David R. Liu,et al.  Directed evolution of ligand dependence: small-molecule-activated protein splicing. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Hanover,et al.  O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.

[39]  Roger Y Tsien,et al.  Identification of a signal for rapid export of proteins from the nucleus , 1995, Cell.

[40]  S. Fawell,et al.  Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. , 1993, Molecular endocrinology.

[41]  R. Laskey,et al.  A polypeptide domain that specifies migration of nucleoplasmin into the nucleus , 1982, Cell.